A Roadmap For mRNA Manufacturing Success
Sponsored by:
Sponsored by:
More from Manufacturing
The country’s life sciences investment head tells Scrip that it is business as usual for the sector despite the rumblings from across the Atlantic.
The Belgian drugmaker is boosting its biologics capacity over the pond.
Will Zydus’s acquisition and licensing deal with Agenus turn out to be a strategic move towards building an oncology portfolio or an opportunistic one driven by a venture capital mindset?
The French company will start shipping its blockbuster shortly to meet expected strong demand in the 2025–26 RSV season.
More from Business
Join Andrew Warmington, Manufacturing Editor at Citeline, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics.
Insights from Novotech on Evolving Trends Impacting Global Clinical Development
Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system
Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.